Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Mesothelioma In Australia, 1945-2000.

J. Leigh, P. Davidson, L. Hendrie, D. Berry
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Australia has maintained a total national malignant mesothelioma case register since 1980. There has been a marked increase in the incidence of mesothelioma in the last 20 years. Currently 450-600 cases are notified annually in a population of 20 million. While the history of the Wittenoom (Western Australia) crocidolite mine and its aftermath is well known, these cases comprise only 5% of the total. This study describes the incidence of mesothelioma in Australia from 1945 to 2000. METHODS Using register data, time trends in mesothelioma incidence were calculated. Analyses of incidence are reported by age, sex, anatomical site, and state of notification. Associations with occupational and environmental asbestos exposure histories are described. Lung fiber content measurements were made on a subset of cases. RESULTS Australia has had 6,329 cases of mesothelioma from 1 January 1945 to 31 December 2000. (A further 620 cases were notified in the period from 1 January 2001 to 31 October 2001.) Annual incidence rates for Australia per million population > or = 20 years (1997) were: male, 59.8; female, 10.9; total, 35.4. Incidence rates have been continually increasing and are the highest reported national rates in the world. While Western Australia has the highest rate (1997 total rate, 52.8), most cases arise from the two most populous eastern states, New South Wales and Victoria. In 88% (male 90%, female 61%) of cases, a history of asbestos exposure was obtained. Exposures occurred in a wide variety of occupational and environmental circumstances. In 80% of cases with no history of exposure, TEM lung asbestos fiber counts > 200,000 fibers > 2 microm length per gm dry lung were obtained, suggesting unrecognized exposure. CONCLUSIONS Australia's high incidence of mesothelioma is related to high past asbestos use, of all fiber types, in a wide variety of occupational and environmental settings. The number of cases in total is expected to be about 18,000 by 2020, with about 11,000 yet to appear.
This paper references
10.5694/j.1326-5377.1969.tb107341.x
FIFTEEN CASES OF PLEURAL MESOTHELIOMA ASSOCIATED WITH OCCUPATIONAL EXPOSURE TO ASBESTOS IN VICTORIA
J. Milne (1969)
10.1111/j.1445-5994.1991.tb01355.x
Miliary spread of malignant pleural mesothelioma without a clinically identifiable pleural tumour
A. Musk (1991)
10.5694/J.1326-5377.1962.TB24396.X
Malignant pleural mesothelioma in an asbestos worker.
Mcnulty Jc (1962)
10.5694/j.1326-5377.1989.tb136455.x
The incidence of malignant mesothelioma in Australia, 1947‐1980
A. Musk (1989)
10.1002/AJIM.4700210512
Wittenoom, Western Australia: a modern industrial disaster.
A. Musk (1992)
10.1093/ANNHYG/38.INHALED_PARTICLES_VII.631
Dose-Response Relationship Between Airborne and Lung Asbestos Fibre Type, Length and Concentration, and the Relative Risk of Mesothelioma
Alan Rogers (1994)
10.1539/joh.41.8
Ecological Relationship between Mesothelioma Incidence/Mortality and Asbestos Consumption in Ten Western Countries and Japan
K. Takahashi (1999)
10.1002/1097-0142(19910701)68:1<135::AID-CNCR2820680125>3.0.CO;2-S
Lung asbestos fiber content and mesothelioma cell type, site, and survival
J. Leigh (1991)
10.5694/j.1326-5377.1968.tb83135.x
ASBESTOS EXPOSURE AND PLEURAL MESOTHELIOMAS
R. Mortimer (1968)
Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started.
T. Kjellstrom (2000)
10.1136/oem.48.12.793
Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers.
G. Berry (1991)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
10.1111/J.1445-5994.1993.TB00532.X
Clinical aspects of malignant mesothelioma in Australia.
T. Driscoll (1993)
10.1093/ANNHYG/28.1.1
Determination of mineral fibre in human lung tissue by light microscopy and transmission electron microscopy.
A. Rogers (1984)
10.1002/(SICI)1097-0274(199602)29:2<183::AID-AJIM8>3.0.CO;2-T
Unrecognized asbestos-induced disease.
M. C. Barroetavena (1996)
Case note: WTO panel Report (WT/DS135/R, European Communities - Measures Affecting Asbestos and Asbestos-containing Products: Responsible Decision-makers, Do it Jourself: The Panel Report in the Asbestos Case)
J. Wiers (2001)
10.1002/1097-0274(200007)38:1<1::AID-AJIM1>3.0.CO;2-9
Leukemia after exposure to benzene: temporal trends and implications for standards.
M. Finkelstein (2000)
10.5694/J.1326-5377.1966.TB97331.X
Three cases of mesothelioma.
Riddell Rj (1966)
10.1093/ANNHYG/41.INHALED_PARTICLES_VIII.161
Malignant mesothelioma in Australia (1945–1995)
J. Leigh (1997)
10.1164/AJRCCM.150.6.7952604
Fiber burden and asbestos-related lung disease: determinants of dose-response relationships.
M. Becklake (1994)
10.5694/j.1326-5377.1989.tb139629.x
Predictions of future cases of asbestos‐related disease among former miners and millers of crocidolite in Western Australia
Nicholas H. de Klerk (1989)
10.1002/AJIM.4700200507
The incidence of malignant mesothelioma in Australia 1982-1988.
J. Leigh (1991)
10.1002/(SICI)1097-0142(19970901)80:5<948::AID-CNCR17>3.0.CO;2-W
Incidence of malignant pleural mesothelioma after thoracic radiotherapy
A. Neugut (1997)
10.5271/SJWEH.567
International expert meeting on new advances in the radiology and screening of asbestos-related diseases.
A. Tossavainen (2000)
10.1002/1097-0142(19910401)67:7<1912::AID-CNCR2820670716>3.0.CO;2-Y
Relationship between lung asbestos fiber type and concentration and relative risk of mesothelioma. A case‐control study
A. J. Rogers (1991)
10.1136/oem.56.8.505
Mesothelioma: cases associated with non-occupational and low dose exposures.
G. Hillerdal (1999)
10.5694/j.1326-5377.1987.tb133348.x
The Australian Mesothelioma Surveillance Program 1979‐1985
David A. Ferguson (1987)



This paper is referenced by
10.1111/j.1743-7563.2007.00116.x
Management of malignant pleural mesothelioma
A. Nowak (2007)
10.1080/00313020400010955
After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004.
D. Henderson (2004)
Occupational cancers/Link between occupation and cancer
(2018)
10.1097/01.jom.0000091682.95314.01
Estimating the Induction Period of Pleural Mesothelioma From Aggregate Data on Asbestos Consumption
Markku Mikael Nurminen (2003)
10.1177/030089160308900405
Malignant Mesothelioma in Rome and Latium Region, 1993-2001
V. Ascoli (2003)
10.5094/APR.2011.051
Airborne asbestos fibres and mesothelioma in the last 20 years in Egypt: a review
A. Awad (2011)
10.1080/10937404.2016.1195323
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States
R. Lemen (2016)
10.1056/NEJMCPC0900637
Case 14-2009: A 36-Year-Old Man with Chest Pain, Dysphagia, and Pleural and Mediastinal Calcifications
Richard Clarke Cabot (2009)
10.1016/S0398-7620(05)84726-1
Évaluation quantitative du risque de cancer du poumon et de mésothéliome pleural chez les mécaniciens de véhicules automobiles
E. Imbernon (2005)
10.1118/1.1688211
Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.
S. Armato (2004)
10.1186/1477-7819-12-112
Malignant peritoneal mesothelioma with lymph node metastasis that originated in the transverse colon
Y. Takehara (2014)
10.1097/COC.0b013e318256f5ba
An Open-label Phase I Pilot Study of Continuous Intrapleural Infusion of Escalated Doses of Methotrexate in Malignant Pleural Mesothelioma
M. Ellithy (2013)
Adjuvant methods to identify and type tumor cells in serous effusions
F. Onofre (2008)
10.1016/S1579-2129(06)60209-7
[Emerging pleuropulmonary diseases associated with asbestos inhalation].
C. Martínez (2004)
10.1136/oem.2010.062182
Trends in mesothelioma mortality rates in South Africa: 1995–2007
D. Kielkowski (2011)
10.1007/978-3-030-16884-1_1
Epidemiology of Mesothelioma
D. Mirabelli (2019)
Aspects épidémiologiques, cliniques et histopathologiques du mésothéliome malin myxoïde : à propos d’une étude de 140 cas
O. Stephanov (2016)
10.2486/INDHEALTH.46.535
Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population.
E. Park (2008)
Praktische consequenties van het advies van de Gezondheidsraad inzake asbest 2010 : Een gezamenlijk rapport van TNO en RIVM
J. Tempelman (2010)
10.1097/PAS.0b013e318218985b
Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation
M. Shi (2011)
10.1158/1078-0432.CCR-06-0472
Megakaryocyte Potentiation Factor Cleaved from Mesothelin Precursor Is a Useful Tumor Marker in the Serum of Patients with Mesothelioma
M. Onda (2006)
A Novel Treatment for Malignant Mesothelioma by use of Cell Penetrating Peptide Based Kinase Inhibition
Isabella Lyn Gore (2017)
10.1093/PUBMED/FDH116
High incidence of mesothelioma in an English city without heavy industrial use of asbestos.
W. Hamilton (2004)
10.1007/s00520-018-4357-0
“It sort of hit me like a baseball bat between the eyes”: a qualitative study of the psychosocial experiences of mesothelioma patients and carers
S. Girgis (2018)
10.5124/JKMA.2009.52.5.442
Occupational and Environmental Asbestos Exposure in Korea
J. Koo (2009)
10.1177/1420326X03039065
Mesothelioma in Cappadocian Villages
A. Dogan (2003)
[The role of asbestos fibre dimensions in the pathogenesis and prevention of mesothelioma].
L. Tomatis (2006)
10.3390/ijerph15020384
Australia’s Ongoing Legacy of Asbestos: Significant Challenges Remain Even after the Complete Banning of Asbestos Almost Fifteen Years Ago
M. Soeberg (2018)
Malignant Pleural MesotheliomaPractice Guidelines in Oncology
R. Martins (2012)
Report from the Food and Drug Administration Pemetrexed in Malignant Pleural Mesothelioma
Maitreyee Hazarika (2005)
10.1007/978-3-319-40618-3_37
Malignant pleural mesothelioma.
D. Ettinger (2012)
10.1080/10937404.2016.1195322
Environmental risk of mesothelioma in the United States: An emerging concern—epidemiological issues
F. Baumann (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar